Identifying Trends that are Redefining Patient Care

Toby King is a Senior Managing Director in Investment Banking at Leerink Partners, focused on the Healthcare Provider continuum. With over 20 years of Healthcare Investment Banking experience, he has advised some of the industry’s leading healthcare providers and private equity firms across a wide variety of situations.

Prior to joining the Firm in 2021, from Citigroup, where Mr. King spent more than a decade, most recently as Managing Director and Head of North America Healthcare leading efforts with individual coverage across hospitals, alternate-site providers, behavioral health, outsourcing and post-acute care. Prior to Citigroup, he spent over ten years in the Healthcare Group at Merrill Lynch. Prior to investment banking, he worked at HCA’s Corporate Finance and Development group.

Mr. King earned a B.A. from Bellarmine University and an MBA from The University of Chicago, Booth School of Business.

Philip Boyd is a Senior Managing Director in Investment Banking at Leerink Partners. He has advised a wide variety of clients on mergers and acquisitions, divestitures, spin-offs, recapitalizations, leveraged buyouts, takeover defense, and capital raising.

Prior to joining the Firm in 2024, Mr. Boyd spent nearly a decade at Guggenheim Securities in the healthcare services sector, where he led strategic transactions for public and private companies. Earlier in his career, he was an associate in Citigroup’s Healthcare Investment Banking Group.

Mr. Boyd earned his B.S. in Applied Economics and Management and his MBA from Cornell University.

Ben Brown is a Senior Managing Director in Investment Banking at Leerink Partners and leads the Firm’s Pharma Services practice. With over 20 years of experience, he has executed M&A and equity transactions for clients across several verticals, including pharma outsourcing and IT, payor and provider services, healthtech, software, consulting and human capital services.

Prior to joining the Firm in 2021, Mr. Brown spent over 15 years at Baird where he was most recently a Managing Director and Head of Global Pharma Services Investment Banking. Prior to Baird, he held investment banking and private equity positions with Thomas Weisel Partners, The Halifax Group, Growth Capital Partners and Prudential Capital Group.

Mr. Brown earned a B.B.A. from Southern Methodist University (cum laude) and an MBA from Northwestern University, Kellogg School of Management.

Michael Clifford is a Senior Managing Director in Investment Banking at Leerink Partners, covering Healthcare Technology and Services and supporting the Firm’s Mergers & Acquisitions efforts. With more than 13 years of Healthcare Investment Banking experience, he has led the execution of strategic transactions for a variety of public and private companies on mergers & acquisitions, equity offerings (IPOs, follow-ons and private placements), acquisition financings and debt financings.

Prior to joining the Firm in 2015, Mr. Clifford worked in the Consumer and Healthcare Investment Banking Group at Wells Fargo Securities, covering healthcare technology and services verticals. Prior to Wells Fargo Securities, he worked in the Transaction Services group at PwC in New York.

Mr. Clifford earned a BSBA (cum laude) in Financial Management & Investments and Accounting from the University of Arkansas.

Robert Jackey is a Senior Managing Director in Investment Banking at Leerink Partners and is focused on coverage for Physician Services and Healthcare Provider companies.

Prior to joining the Firm in 2021, Mr. Jackey served as a Managing Director at Citigroup, covering the alternate site / sub-acute, behavioral, clinical staffing / outsourcing, dental, hospital / acute care, patient transportation, physician organization and veterinary verticals. With over 18 years of Healthcare Investment Banking experience, he has led efforts to execute strategic transactions for a variety of public and private companies. Mr. Jackey’s advisory and execution experience spans the spectrum of traditional provider organizations through high-growth healthcare disruptors, including domestic and multinational corporations.

Mr. Jackey earned his B.S. (summa cum laude) in electrical engineering as well as an MBA from Fairleigh Dickinson University.

Michael Lindenberg is a Senior Managing Director in Investment Banking at Leerink Partners primarily focused on physician services, multi-site healthcare and alternative site subsectors, as well as developing the Firm’s financial sponsor coverage efforts. With over 14 years of healthcare services-focused investment banking experience, Mr. Lindenberg has advised a wide variety of financial sponsor and strategic clients on mergers and acquisitions, divestitures, restructurings, recapitalizations, buyouts, and capital raise transactions.

Prior to joining the Firm in 2021, Mr. Lindenberg focused on advising companies and financial sponsors across the healthcare services ecosystem at Guggenheim Securities. Prior to that, he was a Vice President in Jefferies Group’s Healthcare Investment Banking practice, having started his U.S. advisory career in the Life Sciences team of Deloitte’s Financial Advisory Services group in New York.

Mr. Lindenberg earned his Bachelor’s degree from Stellenbosch University in South Africa and his MBA from the University of Rochester in New York.

Michael Lindenberg is a Senior Managing Director in Investment Banking at Leerink Partners primarily focused on physician services, multi-site healthcare and alternative site subsectors, as well as developing the Firm’s financial sponsor coverage efforts. With over 14 years of healthcare services-focused investment banking experience, Mr. Lindenberg has advised a wide variety of financial sponsor and strategic clients on mergers and acquisitions, divestitures, restructurings, recapitalizations, buyouts, and capital raise transactions.

Prior to joining the Firm in 2021, Mr. Lindenberg focused on advising companies and financial sponsors across the healthcare services ecosystem at Guggenheim Securities. Prior to that, he was a Vice President in Jefferies Group’s Healthcare Investment Banking practice, having started his U.S. advisory career in the Life Sciences team of Deloitte’s Financial Advisory Services group in New York.

Mr. Lindenberg earned his Bachelor’s degree from Stellenbosch University in South Africa and his MBA from the University of Rochester in New York.